Please login to the form below

Not currently logged in
Email:
Password:

Simponi Aria

This page shows the latest Simponi Aria news and features for those working in and with pharma, biotech and healthcare.

FDA approves intravenous Simponi for arthritis treatment

FDA approves intravenous Simponi for arthritis treatment

FDA approves intravenous Simponi for arthritis treatment. J&J says Simponi Aria will offer less frequent dosing schedule than subcutaneous version. ... of 30 minutes with a dosing regimen of every 8 weeks,” said Rob Bazemore, president of Janssen

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics